JACC. Case reports
Focal Atrial Tachycardia During Central Gemcitabine Administration.
Jaspal Singh Gill, Akansha Sethi, Marco Pinto, Andrew D'Silva, Shaumik Adhya, John Whitaker
Published: 202610.1016/j.jaccas.2025.106302
Abstract
BACKGROUND: Gemcitabine is not usually regarded as a cardiotoxic or significantly arrhythmogenic chemotherapeutic agent. CASE SUMMARY: A 66-year-old woman developed narrow complex tachycardia immediately after gemcitabine administration via periphera…
Preview only. Read the full abstract at the source